BioCentury
ARTICLE | Clinical News

Simcor niacin/simvastatin regulatory update

December 21, 2009 8:00 AM UTC

Abbott submitted an sNDA to FDA for 500/40 and 1000/40 mg dosage strengths of Simcor niacin extended release/simvastatin to treat mixed dyslipidemia and hyperlipidemia. FDA approved 500/20, 750/20 and...